BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31537867)

  • 21. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
    Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
    Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis.
    Brown CE; Warden CD; Starr R; Deng X; Badie B; Yuan YC; Forman SJ; Barish ME
    PLoS One; 2013; 8(10):e77769. PubMed ID: 24204956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic mutations in high grade gliomas of the adult spinal cord.
    Nagaishi M; Nobusawa S; Yokoo H; Sugiura Y; Tsuda K; Tanaka Y; Suzuki K; Hyodo A
    Brain Tumor Pathol; 2016 Oct; 33(4):267-269. PubMed ID: 27236270
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
    Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
    Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Alterations in miRNA Expression in Matched Tissue and Blood Samples during Spinal Cord Glioma Progression.
    An T; Fan T; Zhang XQ; Liu YF; Huang J; Liang C; Lv BH; Wang YQ; Zhao XG; Liu JX; Fu YH; Jiang GJ
    Sci Rep; 2019 Jun; 9(1):9169. PubMed ID: 31235820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the potential biomarkers in patients with glioma: a weighted gene co-expression network analysis.
    Chen TY; Liu Y; Chen L; Luo J; Zhang C; Shen XF
    Carcinogenesis; 2020 Jul; 41(6):743-750. PubMed ID: 31761927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
    J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas.
    Sloan EA; Cooney T; Oberheim Bush NA; Buerki R; Taylor J; Clarke JL; Torkildson J; Kline C; Reddy A; Mueller S; Banerjee A; Butowski N; Chang S; Mummaneni PV; Chou D; Tan L; Theodosopoulos P; McDermott M; Berger M; Raffel C; Gupta N; Sun PP; Li Y; Shah V; Cha S; Braunstein S; Raleigh DR; Samuel D; Scharnhorst D; Fata C; Guo H; Moes G; Kim JYH; Koschmann C; Van Ziffle J; Onodera C; Devine P; Grenert JP; Lee JC; Pekmezci M; Phillips JJ; Tihan T; Bollen AW; Perry A; Solomon DA
    Acta Neuropathol; 2019 Nov; 138(5):877-881. PubMed ID: 31515627
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of gene expression profiles associated with glioma progression.
    Hu G; Wei B; Wang L; Wang L; Kong D; Jin Y; Sun Z
    Mol Med Rep; 2015 Aug; 12(2):1884-90. PubMed ID: 25845910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Driver Genetic Mutations in Spinal Cord Gliomas Direct the Degree of Functional Impairment in Tumor-Associated Spinal Cord Injury.
    Nagashima Y; Nishimura Y; Ohka F; Eguchi K; Aoki K; Ito H; Nishii T; Oyama T; Hara M; Kitano Y; Masaki H; Wakabayashi T; Natsume A
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
    Chen J; Hou C; Wang P; Yang Y; Zhou D
    World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.
    Ryall S; Krishnatry R; Arnoldo A; Buczkowicz P; Mistry M; Siddaway R; Ling C; Pajovic S; Yu M; Rubin JB; Hukin J; Steinbok P; Bartels U; Bouffet E; Tabori U; Hawkins C
    Acta Neuropathol Commun; 2016 Aug; 4(1):93. PubMed ID: 27577993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of surgery and radiation therapy on spinal high-grade gliomas: a population-based study.
    Liu J; Zheng M; Yang W; Lo SL; Huang J
    J Neurooncol; 2018 Sep; 139(3):609-616. PubMed ID: 29796723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of PD-L1 expression and T cell infiltration in different molecular subgroups of diffuse midline gliomas.
    Jha P; Manjunath N; Singh J; Mani K; Garg A; Kaur K; Sharma MC; Raheja A; Suri A; Sarkar C; Suri V
    Neuropathology; 2019 Dec; 39(6):413-424. PubMed ID: 31625205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular profiles for insular low-grade gliomas with putamen involvement.
    Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L
    J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.